Overall time to progression for all patients was 13 months, but it was longer in patients with tumor-only mutations than in those with tumor and serum mutations.

所有患者的疾病仅占总体时间为13个月，但是，那些只有肿瘤组织中存在变异的患者的生存期要长于那些肿瘤组织和血浆中均存在变异的患者。

youdao

Overall time to progression for all patients was 13 months, but it was longer in patients with tumor-only mutations than in those with tumor and serum mutations.

所有患者的疾病仅占总体时间为13个月，但是，那些只有肿瘤组织中存在变异的患者的生存期要长于那些肿瘤组织和血浆中均存在变异的患者。

youdao